logo
Plus   Neg
Share
Email

Coty Inc. Proposes $23.25/Shr Cash For Avon Products - Quick Facts

Coty Inc. said it has submitted a non-binding proposal to acquire Avon Products Inc. (AVP) for $23.25 per share in cash in a mutually agreeable and negotiated transaction. The proposal, valued at nearly $10 billion, represents a substantial premium of 27% over the three month volume-weighted average price for Avon shares.

Following extensive but unsuccessful attempts to engage Avon in talks on its proposal, Coty has decided to make its proposal public in order to inform Avon's shareholders of the significant value in a transaction. Also, Coty said it has no intention of pursuing an acquisition on a hostile basis.

Bart Becht, Chairman of the Board of Directors of Coty noted, "Our objective is to engage in discussions with Avon and conduct due diligence so that we and Avon can together determine if there is a basis for a transaction. We believe Avon's shareholders would want their Board to explore with us the benefits to shareholders of a transaction."

Coty, in a letter to Avon's board, expresses desire to open negotiations and Coty also anticipates being able, with Avon's cooperation, to complete due diligence quickly and move forward with a mutually agreeable transaction.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Billionaire entrepreneur Elon Musk on Thursday showed off his concept for the Loop, a high-speed underground public transportation system that will carry up to 16 people and travel at 150 miles per hour. At the Boring Company Information Session, Musk and project leader Steve Davis provided details of the underground mass transit tunnels that the Boring Co. plans to build beneath Los Angeles. Raden has become the second smart luggage company to shut down this month after major U.S. airlines banned smart luggage with non-removable batteries earlier this year. In a statement on its website, Raden said that it is no longer in operation and that all existing shipments have been processed for delivery. The company is shuttering after three years of operation. Shares of AstraZeneca were losing around 2 percent in the London trading after the British drug major reported Friday lower profit in its first quarter amid weak margin, despite growth in product sales. Further, the company reiterated its outlook for fiscal 2018. The level of Externalisation Revenue, divestment timing and investment in launches impacted the overall results.
Follow RTT